![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Zoledronic acid cost effective in preventing AI-associated bone loss
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Risedronic acid abrogates anastrozole-induced bone loss
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)